Inhalation Sciences Sweden AB Stock OTC Markets
Stocks
INHSF
SE0009983893
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 07-29 | Inhalation Sciences secures financing of up to €0.4m | FW |
| 06-16 | Inhalation Sciences Secures SEK 0.4m Research Grant | FW |
| Market Cap | 9.47M 996K 865K 810K 741K 1.4M 94.91M 1.42M 3.72M 47.42M 3.74M 3.66M 158M | P/E 2024 |
-12.8x | P/E 2025 | -12.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.64M 699K 606K 568K 519K 980K 66.54M 993K 2.61M 33.25M 2.62M 2.57M 111M | EV / Sales 2024 |
5.6x | EV / Sales 2025 | 55x |
| Free-Float |
94.25% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Manoush Masarrat
CEO | Chief Executive Officer | - | 16/09/2019 |
Per Magnus Gerde
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2005 |
Ulf Wedenberg
PRN | Corporate Officer/Principal | - | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Per Magnus Gerde
BRD | Director/Board Member | - | 01/01/2005 |
Jan Hellqvist
BRD | Director/Board Member | - | 01/09/2022 |
Ulf Ericsson
BRD | Director/Board Member | - | 01/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 998K | |
| -0.64% | -0.48% | +27.86% | +4.03% | 214B | |
| -0.84% | +0.76% | +1.28% | -22.67% | 140B | |
| -0.10% | +6.20% | -20.93% | +21.22% | 133B | |
| +3.94% | +7.86% | -51.81% | -2.20% | 69.19B | |
| -0.14% | +2.15% | +12.95% | +11.21% | 51.28B | |
| -0.36% | +5.11% | -14.27% | -19.86% | 50.43B | |
| -0.73% | +1.00% | +23.73% | +10.74% | 39.85B | |
| -1.37% | +4.37% | +42.92% | +37.00% | 39.27B | |
| -0.07% | +7.46% | -20.09% | +20.06% | 32.32B | |
| Average | +0.01% | +3.77% | +0.18% | +6.61% | 85.43B | |
| Weighted average by Cap. | -0.12% | +3.04% | +2.21% | +3.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 11.05M 1.16M 1.01M 944K 864K 1.63M 111M 1.65M 4.34M 55.31M 4.36M 4.27M 184M | 3.04M 320K 278K 260K 238K 449K 30.47M 455K 1.19M 15.22M 1.2M 1.17M 50.67M |
| Net income | -5.15M -541K -470K -440K -402K -760K -51.57M -770K -2.02M -25.77M -2.03M -1.99M -85.77M | -10.16M -1.07M -927K -868K -794K -1.5M -102M -1.52M -3.99M -50.87M -4.01M -3.93M -169M |
| Net Debt | -4M -421K -365K -342K -313K -591K -40.11M -599K -1.57M -20.04M -1.58M -1.55M -66.71M | -2.83M -298K -258K -242K -221K -418K -28.37M -423K -1.11M -14.17M -1.12M -1.09M -47.18M |
Employees
5
Calendar
Net sales - Rate of surprise
- Stock Market
- Stocks
- ISAB Stock
- INHSF Stock
Select your edition
All financial news and data tailored to specific country editions
